The J-code for @GlaukosCorp's iDose TR is effective as of today.
Take a look back at @GoHealio's initial coverage of the announcement, featuring Glaukos' own Cody McKenzie, from @ASCRStweets for all the details! 👇
#OcularSurgeryNews#glaucoma
https://t.co/l6FEKgLTGG
It's time to think beneath the lenses. Refer your progressive KC patients for iLink® corneal cross-linking and help save their vision. Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. ISI: https://t.co/8U97Ssk7K1
iLink® offers patients FDA-approved intervention to slow or halt progressive keratoconus and help preserve their vision. Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. ISI: https://t.co/8U97Ssk7K1
Join us live 11/14 at 7pmCT for our iStent infinite® Live Surgery Showcase by @blakewilly, featuring @ManjoolShah and @DeborahRistvedt.
Register here ➡️
https://t.co/bdAh062ohu
Visit https://t.co/UxTgPATSST for Important Safety Information .
Get ready for an enriching and educational experience at AAOpt 2023! We're thrilled to visit New Orleans ⚜️ and be among so many great minds. Swing by booth #1513 for an up-close look at the game-changing advancements from Glaukos.
#AAOpt2023#Glaukos
iStent infinite® gives you the power to deliver optimized treatment for patients who have failed prior medical and surgical intervention. Learn more about what iStent infinite® can do for your practice today.
ISI: https://t.co/UxTgPATSST
In Ep97 of #OpenYourEyes with @drkerrygelb, @nedashamie explains the importance of early KC diagnosis. Watch here: https://t.co/JZEFhOASNy
Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. ISI: https://t.co/8U97Ssk7K1
Watch the Katie Gilbert-Spear, OD, JD, MPH & @OptometryTimes interview "VEE 2023: Legal perspective on keratoconus management" https://t.co/NF8uYKV5g6. Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. ISI: https://t.co/8U97Ssk7K1
iStent infinite® is a first-of-its-kind standalone implantable alternative with 3 anatomically designed stents preloaded into an elegant injector system.
Visit https://t.co/UxTgPATSST for Important Safety Information.
In "Keratoconus and perfect vision: Is it possible?," @wtrattler & @DrEliseKramer warn that clinicians should be aware that 20/20 vision and a normal slit lamp exam does not rule out corneal disease. Read more: https://t.co/ULkslzGmtn
In this clip from Episode 1 of #MIGSMinute from @GlaucomaPhys, @ipsingheyedoc & @ikekahmed discuss where the concept of MIGS started and why it's inclusion with cataract surgery made sense.
Watch the full episode ➡️ https://t.co/2aCTDEybKJ
After 25 years, Glaukos has a rich history of milestones and achievements, but what really matters are the untold successes that are yet to come. Join us in celebrating just a few of those incredible peaks in our timeline! 🎉
Thanks for joining experienced sleuths @drbobbysaenz, @mitchelibach, @TracySSwartz256 & Susan Gromacki, OD, MS, FAAO, FSLS at the iDetectives Keratoconus Spy Summit on Wednesday, June 21st! #FollowTheClues to detect KC early; prompt detection enables timely intervention.
iStent infinite® is designed to provide powerful technology to deliver foundational, 24/7, long-term IOP control in patients with glaucoma who have failed prior medical and surgical intervention.
Visit https://t.co/UxTgPATSST for Important Safety Information.